Vaccines of the 21st Century and Vaccinomics: Data-Enabled Science Meets Global Health to Spark Collective Action for Vaccine Innovation

Avard D. , Stanton-Jean M. , Grégoire G. , Page M . 2010. Public involvement in health genomics: the reality behind the policies. Int J Consum Stud, 34:508–524.

Brice P. 2011. WHO grand challenges in genomics for developing countries. Public Health Genomics Foundation Newsletter, June 8, 2011. http://www.phgfoundation.org/news/8728/. 2011 June 27).

Burke W. , Burton H. , Hall A.E. , Karmali M. , Khoury M.J. , Knoppers B. et al. 2010. Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and “personalized” medicine? Genet Med, 12:785–791.

Carlile P.R. 2004. Transferring, translating, and transforming: an integrative framework for managing knowledge across boundaries. Organizat Sci, 15:555–568.

Condit C. 2001. What is “public opinion” about genetics? Nat Rev Genet, 2:811–815.

Contandriopoulos D. , Denis J.-L. , Langley A. 2004. Defining the “public” in a public healthcare system. Hum Relat, 57:1573–1593.

Daar A.S. 2010. Chronic non-communicable diseases as a threat for all: recent global initiatives. Sultan Qaboos Univ Med J, 10:306–309.

Einsiedel E.F. 2011. Publics and vaccinomics: beyond public understanding of science. OMICS, 15, this issue.

European Commission. 2007. EUR 22700—Science & Governance—Taking European Knowledge Society Seriously. Luxembourg: Office for Official Publications of the European Communities. http://ec.europa.eu/research/science-society/document_library/pdf_06/european-knowledge-society_en.pdf. 2011 June 27).

Faraj S. , Yan A. 2009. Boundary work in knowledge teams. Appl Psychol, 94:604–617.

Hayeems R.Z. , Miller F.A. , Li L. , Bytautas J.P . 2011. Not so simple: a quasi-experimental study of how researchers adjudicate genetic research results. Eur J Hum Genet, 19:740–747.

Hotez P.J. 2011. New antipoverty drugs, vaccines, and diagnostics: a research agenda for the US President's Global Health Initiative (GHI) PLoS Negl Trop Dis, 5:e1133.

Jasanoff S. 2006. States of Knowledge: The Co-Production of Science and Social Order. London: Routledge.

Kasperson R.E. 1986. Six propositions on public participation and their relevance for risk communication. Risk Anal, 6:275–281.

Khoury M.J. , Bowen S. , Bradley L.A. , Coates R. , Dowling N.F. , Gwinn M. et al. 2009. A decade of public health genomics in the United States: Centers for Disease Control and Prevention 1997–2007. Public Health Genomics, 12:20–29.

Khoury M.J. 2011. Public health genomics: the end of the beginning. Genet Med, 13:206–209.

Kickbusch I. 2005. Tackling the political determinants of global health. BMJ, 331:246–247.

Kickbusch I. 2011. Global health diplomacy: how foreign policy can influence health. BMJ, 342:d3154.

Knoppers B.M. , Leroux T. , Doucet H. , Godard B. , Laberge C. , Stanton-Jean M. et al. 2010. Framing genomics, public health research and policy: points to consider. Public Health Genomics, 13:224–234.

Kolker E. 2011. Special issue on data-intensive science. OMICS, 15:197–198.

Lehoux P. 2011. Moving beyond our mutual ignorance. Or, how would engaging the public benefit the personalized medicine community? Curr Pharmacogenomics Person Med, 9:76–79.

Majchrzak A. , More P.H.B. , Faraj S. 2011. Transcending knowledge differences in cross-functional teams. Organizat Sci. (in press).

Marmot M. 2010. BMA presidency acceptance speech: fighting the alligators of health inequalities. BMJ, 341:c3617.

National Science Foundation. 2011. Office of Cyberinfrastructure. Advisory Committee for Cyberinfrastucture (ACCI) Task Force Reports. http://www.nsf.gov/od/oci/taskforces/. 2011 June 27.

Nowotny H. , Scott P. , Gibbons M. 2001. Re-Thinking Science: Knowledge and the Public in an Age of Uncertainty. Cambridge: Polity Press.

O'Leary P. , Zimmern R.L. 2010. Genomics and public health: translating research into public benefit. Public Health Genomics, 13:193–196.

Ommer R. , Wynne B. , Downey R. , Fisher E. , Marden E. , Kosseim P. et al. 2011. Pathways to Integration. Vancouver: Genome British Columbia GSEAC Subcommittee on Pathways to Integration www.genomebc.ca/index.php/download_file/view/611/910/. 2011 June 27.

O'Neill O. 2011. Broadening bioethics: clinical ethics, public health and global health. Nuffield Council on Bioethics Annual Lecture. http://www.nuffieldbioethics.org/news/broadening-bioethics-clinical-ethics-public-health-and-global-health. 2011 June 27.

Ostrom E. 1990. Governing the Commons: The Evolution of Institutions for Collective Action. Cambridge: Cambridge University Press.

Ozdemir V. 2010. Pharmacogenomics: Reflections on the old and new social, ethical and policy issues in postgenomics medicine. Pharmacogenomics in Psychiatry Advances in Biological Psychiatry. M. Schwab , Kaschka W. , Spina E. Karger: Basel, 12–29.

Ozdemir V. , Suarez-Kurtz G. , Stenne R. , Somogyi A.A. , Someya T. , Kayaalp S.O. et al. 2009. Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of “edge effect” and cultivating an ethical bridge between omics innovations and society. OMICS, 13:43–61.

Pang T. 2011. No Health Without Research—World Health Report for 2012. http://blogs.plos.org/speakingofmedicine/2011/01/25/no-health-without-research-–-world-health-report-for-2012/. 2011 June 27.

Poland G.A. 2007. Pharmacology, vaccinomics, and the second golden age of vaccinology. Clin Pharmacol Ther, 82:623–626.

Poland G.A. , Ovsyannikova I.G. , Jacobson R.M. , Smith D.I. 2007. Heterogeneity in vaccine immune response: The role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther, 82:653–664.

Program for Appropriate Technology in Health. 2011. Sparking Innovation to Save Lives: How the US Can Advance Global Health Through New Technologies. Washington, DC: Global Health Technologies Coalition.

Schofield P.N. , Eppig J. , Huala E. , de Angelis M.H. , Harvey M. , Davidson D. et al. 2010. Sustaining the data and bioresource commons. Science, 330:592–593.

The White House, Office of the Press Secretary. (May 5, 2009). Statement by the President on Global Health Initiative [press release] http://www.whitehouse.gov/the_press_office/Statement-by-the-President-on-Global-Health-Initiative. 2011 June 24.

Thomas C. , Moridani M. 2010. Interindividual variations in the efficacy and toxicity of vaccines. Toxicology, 278:204–210.

Thorsteinsdóttir H. , Melon C.C. , Ray M. , Chakkalackal S. , Li M. , Cooper J.E. et al. 2011. South–South entrepreneurial collaboration in health biotech. Nat Biotechnol, 28:407–416.

University of California. 2009. The importance of the global health sector in California: an evaluation of the economic impact. http://www.ucghi.universityofcalifornia.edu/docs/eir-final.pdf. 2011 June 27.

Walport M. , Brest P. 2011. Sharing research data to improve public health. Lancet, 377:537–539.

Wynne B. 2006. Public engagement as a means of restoring public trust in science— hitting the notes, but missing the music? Community Genet, 9:211–220.

Zawati M. , Hendy M. , Joly Y. 2011. Incidental findings in data intensive postgenomics science and legal liability of clinician-researchers: ready for vaccinomics? OMICS, 15, this issue.